mortality/aging
• after i.p. infection with encephalomyocarditis virus (EMCV)
|
immune system
• 12 h after i.v. inoculation with EMCV, serum interferon-alpha levels are markedly lower than those in similarly infected wild-type controls
|
• 12 h after i.v. inoculation with EMCV, serum interferon-beta levels are markedly lower than those in similarly infected wild-type controls
• in contrast, 12 h after i.v. inoculation with vesicular stomatitis virus (VSV, Indiana strain), serum interferon-beta levels are comparable to those in wild-type controls
|
• following infection with EMCV, IFN-alpha secretion by bone marrow derived macrophages (BMDMs) is completely inhibited
• in contrast, following infection with VSV, IFN-alpha secretion by BMDMs is normal
|
• following EMCV infection, induction of IFN-beta mRNA expression and IFN-beta secretion by BMDMs is completely inhibited
• following stimulation with HMW poly I:C or EMCV-RNA, induction of IFN-beta mRNA expression in BMDMs is abrogated
• in contrast, VSV infection-induced IFN-beta secretion by BMDMs is normal
• IFN-beta mRNA expression in BMDMs is also normal following adenovirus infection, or after stimulation with 5'-triphosphate RNA (3pRNA, an agonist for RIG-I), extracellular LPS (agonist for TLR4), poly I:C (agonist for TLR3) or VSV-RNA
|
• 48 h after i.p. infection with encephalomyocarditis virus (EMCV, strain D)
• in contrast, no differences in virus titer are observed in the pancreas 24 h after VSV
|
• after i.p. infection with encephalomyocarditis virus (EMCV)
|
homeostasis/metabolism
• 12 h after i.v. inoculation with EMCV, serum interferon-alpha levels are markedly lower than those in similarly infected wild-type controls
|
• 12 h after i.v. inoculation with EMCV, serum interferon-beta levels are markedly lower than those in similarly infected wild-type controls
• in contrast, 12 h after i.v. inoculation with vesicular stomatitis virus (VSV, Indiana strain), serum interferon-beta levels are comparable to those in wild-type controls
|